Six-year duration of adjuvant imatinib in high-risk GIST: more to come

J. Y. Blay, C. Schiffler, S. Chabaud, D. Perolc, A. Le Cesne

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

Accès au document

@article{37a3e79d422246b7ae3768c691556d38,

title = "Six-year duration of adjuvant imatinib in high-risk GIST: more to come",

author = "Blay, {J. Y.} and C. Schiffler and S. Chabaud and D. Perolc and {Le Cesne}, A.",

year = "2025",

month = mar,

day = "1",

doi = "10.1016/j.annonc.2024.11.013",

language = "English",

volume = "36",

pages = "346--347",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "3",

}

TY - JOUR

T1 - Six-year duration of adjuvant imatinib in high-risk GIST

T2 - more to come

AU - Blay, J. Y.

AU - Schiffler, C.

AU - Chabaud, S.

AU - Perolc, D.

AU - Le Cesne, A.

PY - 2025/3/1

Y1 - 2025/3/1

UR - http://www.scopus.com/inward/record.url?scp=85217515143&partnerID=8YFLogxK

U2 - 10.1016/j.annonc.2024.11.013

DO - 10.1016/j.annonc.2024.11.013

M3 - Letter

C2 - 39631623

AN - SCOPUS:85217515143

SN - 0923-7534

VL - 36

SP - 346

EP - 347

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -